Concepedia

Lynn Chamberlain

LC

7

Publications

525

Citations

7

H-Index

2012

Active since

Affiliations

Howard Hughes Medical Institute(Current)

University of Massachusetts Chan Medical School

Yale University

Lynn Chamberlain is an author at Howard Hughes Medical Institute specializing in medicine, cell biology, and cancer genetics.

Top concepts

Publications per year

2012–2016

7

Publications

7

TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein

Sanchita Bhatnagar, Claude Gazin, Lynn Chamberlain et al. · Nature · 2014 · 182 citations · Full text

, , +13

U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3′ End Formation

Sung Mi Park, Jianhong Ou, Lynn Chamberlain et al. · Molecular Cell · 2016 · 128 citations · Full text

, , +7

Genetic and pharmacological reactivation of the mammalian inactive X chromosome

Sanchita Bhatnagar, Xiaochun Zhu, Jianhong Ou et al. · Proceedings of the National Academy of Sciences · 2014 · 96 citations · Full text

Non-canonical TAF complexes regulate active promoters in human embryonic stem cells

Glenn A. Maston, Lihua Julie Zhu, Lynn Chamberlain et al. · eLife · 2012 · 42 citations · Full text

Analysis of Gal4-directed transcription activation using Tra1 mutants selectively defective for interaction with Gal4

Ling Lin, Lynn Chamberlain, Lihua Julie Zhu et al. · Proceedings of the National Academy of Sciences · 2012 · 31 citations · Full text

Rows per page

1–5 of 7